Linked below, please find a webinar hosted by investment firm Ladenberg Thalmann’s Healthcare Symposia Series, featuring Dr. Charalampos (Haris) Tzoulis, a renowned clinical neurologist and expert on movement disorders and neurodegeneration.
In this webinar, Dr. Tzoulis discusses his clinical experience with nicotinamide riboside (NR). He delves into the lack of treatment options for patients with neurodegenerative diseases, and speaks about the impact of NR in various studies. Through his participation in the ChromaDex External Research Program (CERP), Tzoulis has led or is leading many clinical studies (including several on Parkinson’s disease) that indicate encouraging results in hard-to-treat patient groups.
In addition, there’s a live Q&A at the end of the presentation that you may find enlightening.
You can view the webinar HERE.
Simply register your name and email and you’ll have immediate access. (Source: Chromadex)
Sign Up to Receive China Updates Weekly Newsletter for FREE, HERE
Visit HPA-China’s Information Hub, HERE